PPLI reports today against a backdrop where short sellers hold their most significant positions of the past year — while the broader peer group has quietly outperformed.
Short interest heading into the print is genuinely elevated, with roughly 11.8% of the free float sold short. That figure has climbed 3.3% over the past week even as the stock slipped 0.7% on the week and shed over 10% across the past month, closing Monday at $42.06. The ORTEX short score has held in a tight range around 64 for the past two weeks — not extreme, but consistently elevated, ranking in just the 7th percentile of stocks on a short-score basis, meaning sellers are more committed here than on the vast majority of comparable names. Borrow conditions, however, offer little immediate pressure. Availability is loose at 568% — far above the 52-week floor of 371% — meaning new shorts face no meaningful friction entering positions. Cost to borrow has also eased sharply, down 18% over the past week to a negligible 0.42%, reflecting a lending market with plenty of supply.
Options positioning tells a nuanced story. The put/call ratio has actually drifted lower in recent weeks, to 2.89 from above 3.5 in late July, and sits nearly one standard deviation below its 20-day average of 3.13. For a stock this heavily shorted, that relative easing in put demand is worth noting — options traders are not actively adding downside protection ahead of the print in the way the short interest level might suggest. The PCR remains structurally high in absolute terms, far above 1.0, but directionally it has shifted away from maximum defensiveness in the run-up to results.
The bull and bear debate here centers squarely on what the "People" segment can deliver now that IAC has stripped away Care.com and wound down its Search business. Bulls point to the 1Q26 result, where the core segment beat adjusted EBITDA expectations by a meaningful 12.6%, and argue that asset simplification should narrow the valuation gap over time. The sole analyst consensus rating is a buy, with a mean price target of $52.20 implying roughly 24% upside to the current price — though the consensus data is around five weeks old and no recent target revisions are on record. Bears counter that the divestitures have also shrunk the revenue base, that heavy reliance on further acquisitions for growth is a structural risk, and that Google litigation uncertainty remains an overhang. The P/E multiple has compressed by roughly 15% over the past 30 days, and the stock's price-to-book of 0.67 underscores the market's skepticism about intrinsic value. Among peers, CARG gained 8.6% on the week, YELP 5.3%, and MTCH nearly 4% — all while PPLI drifted lower, a divergence that adds weight to the bear case on relative sentiment.
The earnings print will test whether the People segment's EBITDA momentum from Q1 was durable enough to justify the stock's current price — or whether the compression in multiples and the growing short position reflect a market that has already reached a verdict.
See the live data behind this article on ORTEX.
Open PPLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
